ACTIVE

APOTHEEK BOLLEN-TACK

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

172,6 k €

-12.6% YoY

Gross margin

210,8 k €

-7.5% YoY

Equity

30,9 k €

+1.9% YoY

What does APOTHEEK BOLLEN-TACK do?

APOTHEEK BOLLEN-TACK is a Private limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tienen.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0467.029.462

Incorporation

11/10/1999

Legal form

Private limited company

Registered office

Hannuitsesteenweg 55
3300 Tienen · FlandreSee on map

Contributed capital

20 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Signals

ProfitablePositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	210,8 k €	-7.5%	228 k €	+17.1%	194,7 k €	+47.8%	131,8 k €	-24.6%	174,8 k €	+37.6%	127,1 k €	-5.4%	134,3 k €	-3.2%	138,8 k €	+15.1%	120,6 k €	-2.2%	123,4 k €	+19.4%	103,3 k €	-15.7%	122,6 k €	+19.4%	102,7 k €	-21.3%	130,5 k €	+45.3%	89,8 k €	-4.0%	93,5 k €	+2.1%	91,6 k €	+30.9%	70 k €	+3.4%	67,6 k €	-6.5%	72,3 k €
EBITDA	208,5 k €	-7.5%	225,5 k €	+17.2%	192,4 k €	+49.4%	128,8 k €	-25.5%	172,9 k €	+39.3%	124,1 k €	-5.7%	131,7 k €	+5.2%	125,1 k €	+25.7%	99,5 k €	-7.6%	107,7 k €	+24.1%	86,8 k €	-19.1%	107,2 k €	+22.1%	87,8 k €	-24.6%	116,4 k €	+53.3%	76 k €	-6.0%	80,8 k €	-2.8%	83,1 k €	+38.5%	60 k €	-1.7%	61 k €	-5.8%	64,8 k €
Operating result	192,9 k €	-8.4%	210,6 k €	+17.8%	178,7 k €	+52.5%	117,2 k €	-26.4%	159,2 k €	+115%	73,9 k €	-8.7%	80,9 k €	+10.6%	73,1 k €	+52.1%	48,1 k €	-15.2%	56,7 k €	+57.5%	36 k €	-35.7%	56 k €	+54.3%	36,3 k €	-44.2%	65 k €	+153%	25,7 k €	-61.9%	67,4 k €	+27.9%	52,7 k €	+228%	16 k €	+3.5%	15,5 k €	-51.3%	31,8 k €
Net result	172,6 k €	-12.6%	197,6 k €	+19.2%	165,8 k €	+62.3%	102,1 k €	-28.0%	141,9 k €	+158%	55,1 k €	-9.1%	60,6 k €	-12.0%	68,8 k €	+92.7%	35,7 k €	-19.6%	44,4 k €	+99.6%	22,3 k €	-47.3%	42,3 k €	+97.6%	21,4 k €	-61.2%	55,2 k €	+45.3%	38 k €	-48.5%	73,8 k €	+37.4%	53,7 k €	+417%	10,4 k €	-16.6%	12,5 k €	-49.3%	24,6 k €
Balance sheet
Equity	30,9 k €	+1.9%	30,3 k €	+0.2%	30,2 k €	+6.3%	28,5 k €	+0.5%	28,3 k €	+1.4%	28 k €	+0.3%	27,9 k €	+0.0%	27,9 k €	+0.9%	27,6 k €	+0.1%	27,6 k €	+1.7%	27,1 k €	+1.0%	26,9 k €	+1.0%	26,6 k €	+1.5%	26,2 k €	-68.4%	83 k €	+4.4%	79,5 k €	+2.1%	77,9 k €	+3.9%	75,1 k €	-0.8%	75,7 k €	+19.7%	63,2 k €
Total assets	523,5 k €	+3.0%	508,1 k €	+2.1%	497,8 k €	+3.4%	481,7 k €	-7.9%	522,7 k €	+9.6%	476,9 k €	-15.0%	561 k €	-10.0%	623,5 k €	-4.4%	652,2 k €	-10.1%	725,5 k €	-5.8%	770,1 k €	-11.3%	867,9 k €	-7.0%	932,9 k €	-6.8%	1 M €	-3.4%	1 M €	+49.1%	695,3 k €	+0.1%	694,3 k €	+6.1%	654,5 k €	-1.7%	665,7 k €	+119%	303,7 k €
Cash	106,3 k €	-0.7%	107,1 k €	+282%	28 k €	-13.8%	32,5 k €	+7.8%	30,2 k €	-66.8%	90,8 k €	-26.1%	122,7 k €	-13.1%	141,2 k €	+76.2%	80,1 k €	-41.5%	136,9 k €	+56.6%	87,4 k €	-43.1%	153,8 k €	-9.9%	170,7 k €	+10.7%	154,2 k €	+35.8%	113,5 k €	-2.5%	116,4 k €	+4.3%	111,6 k €	+63.4%	68,3 k €	+7.4%	63,6 k €	+370%	13,5 k €
Debts	484,2 k €	+3.1%	469,6 k €	+4.8%	447,9 k €	-0.5%	450 k €	-7.1%	484,6 k €	+10.3%	439,3 k €	-16.6%	526,5 k €	-11.0%	591,7 k €	-5.0%	623,2 k €	-10.6%	697,4 k €	-5.7%	739,9 k €	-12.0%	840,4 k €	-7.0%	904 k €	-7.1%	973,2 k €	+3.0%	944,8 k €	+53.8%	614,5 k €	+0.2%	613,2 k €	+6.0%	578,5 k €	-1.9%	589,5 k €	+146%	239,3 k €
Other
Workforce	–		0,0 ETP		0,0 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

PHARMA PI MANAGEMENT

Director · 0892.887.869

Represented by Sophie Bollen

Active

Ended mandates

BVBA PHARMA PI MANAGEMENT BVBA

Manager · since 22 octobre 2007

Ended

PHARMA PI MANAGEMENT

Director · since 22 octobre 2007 · 0892.887.869

Represented by Sophie Bollen

Ended

PHARMA PI MANAGEMENT

Manager · since 22 octobre 2007 · 0892.887.869

Represented by Sophie Bollen

Ended

PHARMA PI MANAGEMENT

Manager · since 22 octobre 2007 · 0892.887.869

Ended

At this address

Other companies at this address

Company	CBE no.
PHARMA PI MANAGEMENT● Active	0892.887.869

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	16/07/2026	23/05/2025	18/06/2024	18/08/2023	23/05/2022	25/05/2021
General meeting	26/06/2026	16/05/2025	17/05/2024	19/05/2023	20/05/2022	21/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	16/07/2026	Dutch	PDF
Abridged model	31/12/2024	16/05/2025	23/05/2025	Dutch	PDF
Abridged model	31/12/2023	17/05/2024	18/06/2024	Dutch	PDF
Micro model	31/12/2022	19/05/2023	18/08/2023	Dutch	PDF
Abridged model	31/12/2021	20/05/2022	23/05/2022	Dutch	PDF
Abridged model	31/12/2020	21/05/2021	25/05/2021	Dutch	PDF
Abridged model	31/12/2019	15/05/2020	28/05/2020	Dutch	PDF
Abridged model	31/12/2018	17/05/2019	19/06/2019	Dutch	PDF
Abridged model	31/12/2017	18/05/2018	24/05/2018	Dutch	PDF
Abridged model	31/12/2016	19/05/2017	22/05/2017	Dutch	PDF
Abridged model	31/12/2015	21/05/2016	23/05/2016	Dutch	PDF
Abridged model	31/12/2014	15/05/2015	21/05/2015	Dutch	PDF
Abridged model	31/12/2013	16/05/2014	26/05/2014	Dutch	PDF
Abridged model	31/12/2012	17/05/2013	27/05/2013	Dutch	PDF
Abridged model	31/12/2011	18/05/2012	21/05/2012	Dutch	PDF
Abridged model	31/12/2010	20/05/2011	23/05/2011	Dutch	PDF
Abridged model	31/12/2009	21/05/2010	27/05/2010	Dutch	PDF
Abridged model	31/12/2008	15/05/2009	08/06/2009	Dutch	PDF
Abridged model	31/12/2007	16/05/2008	26/05/2008	Dutch	PDF
Abridged model	31/12/2006	18/05/2007	01/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

PHARMA PI MANAGEMENT

Director · 0892.887.869

Represented by Sophie Bollen

Active

Ended mandates

BVBA PHARMA PI MANAGEMENT BVBA

Manager · since 22 octobre 2007

Ended

PHARMA PI MANAGEMENT

Director · since 22 octobre 2007 · 0892.887.869

Represented by Sophie Bollen

Ended

PHARMA PI MANAGEMENT

Manager · since 22 octobre 2007 · 0892.887.869

Represented by Sophie Bollen

Ended

PHARMA PI MANAGEMENT

Manager · since 22 octobre 2007 · 0892.887.869

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/02/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/11/2007
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares11/01/2007
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025172,6 k €↓
2024
Annual accounts 2024197,6 k €↑
2023
Annual accounts 2023165,8 k €↑
2022
Annual accounts 2022102,1 k €↓
2021
Annual accounts 2021141,9 k €↑
2020
Annual accounts 202055,1 k €↓
2019
Annual accounts 201960,6 k €↓
2018
Annual accounts 201868,8 k €↑
2017
Annual accounts 201735,7 k €↓
2016
Annual accounts 201644,4 k €↑
2015
Annual accounts 201522,3 k €↓
2014
Annual accounts 201442,3 k €↑
2013
Annual accounts 201321,4 k €↓
2012
Annual accounts 201255,2 k €↑
2011
Annual accounts 201138 k €↓
2010
Annual accounts 201073,8 k €↑
2009
Annual accounts 200953,7 k €↑
2008
Annual accounts 200810,4 k €↓
2007
Annual accounts 200712,5 k €↓
2006
Annual accounts 200624,6 k €
11/10/1999
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK BOLLEN-TACK

Overview

What does APOTHEEK BOLLEN-TACK do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline